Sorafenib Impurity INT-2-M

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	APB284462802
CAS	284462-80-2
Structure
Molecular Weight	229.24
Molecular Formula	C12H11N3O2

What is the name of the impurity with CAS number 284462-80-2?

The name of the impurity is Sorafenib Impurity INT-2-M.

What is the molecular weight of Sorafenib Impurity INT-2-M?

The molecular weight is 229.24.

What is the molecular formula of Sorafenib Impurity INT-2-M?

The molecular formula is C12H11N3O2.

Can you explain the significance of Sorafenib Impurity INT-2-M in pharmaceutical research?

Sorafenib Impurity INT-2-M is important in pharmaceutical research as it is an impurity that needs to be monitored and controlled to ensure the quality and safety of the pharmaceutical product.

How is Sorafenib Impurity INT-2-M detected and quantified in pharmaceutical preparations?

Sorafenib Impurity INT-2-M can be detected and quantified using analytical techniques such as chromatography or spectroscopy.

What are some potential sources of Sorafenib Impurity INT-2-M in pharmaceutical manufacturing?

Potential sources of the impurity can include raw materials, reagents, equipment, or process intermediates used in pharmaceutical manufacturing.

Why is it important to have strict specifications for Sorafenib Impurity INT-2-M in pharmaceutical products?

Strict specifications help ensure that the final pharmaceutical product is safe and effective for patient use by controlling the levels of impurities such as Sorafenib Impurity INT-2-M.

Are there regulations or guidelines governing the levels of Sorafenib Impurity INT-2-M in pharmaceutical products?

Yes, regulatory bodies like the FDA or EMA have guidelines on acceptable levels of impurities in pharmaceutical products, including Sorafenib Impurity INT-2-M.

How can the presence of Sorafenib Impurity INT-2-M impact the efficacy of the final pharmaceutical product?

The impurity can potentially affect the stability, efficacy, or safety of the pharmaceutical product, which is why monitoring and controlling levels is crucial.

What steps can pharmaceutical manufacturers take to minimize the presence of Sorafenib Impurity INT-2-M in their products?

Manufacturers can implement rigorous quality control processes, conduct thorough testing, and ensure proper handling and storage of raw materials to minimize impurities like Sorafenib Impurity INT-2-M.

* Products or Services Interested: Sorafenib Impurity INT-2-M (284462-80-2)
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry